characteristics.text: SAMN31998731
characteristics.characteristic: External Id
characteristics.text: ENCODE
characteristics.characteristic: INSDC center name
characteristics.text: 2022-12-02T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2023-01-19T14:13:20.816Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS15958949
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS15958949
characteristics.characteristic: SRA accession
characteristics.text: 58 year
characteristics.characteristic: age
characteristics.text: A549
characteristics.characteristic: cell line
characteristics.text: Homo sapiens A549 cell line treated with 1 uM Mapracorat (agonist) for 4 hours
characteristics.characteristic: description
characteristics.text: adult
characteristics.characteristic: dev stage
characteristics.text: ENCDO000AAZ
characteristics.characteristic: donor ID
characteristics.text: Tim Reddy, Duke
characteristics.characteristic: lab
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: cell line
characteristics.characteristic: sample type
characteristics.text: male
characteristics.characteristic: sex
characteristics.text: ATCC
characteristics.characteristic: source
characteristics.text: ENCODE biosample ENCBS927GRP
characteristics.characteristic: title
characteristics.text: treatment_term_id: CHEBI:177650; treatment_term_name: Mapracorat; treatment_type: chemical; duration: 4; duration_units: hour;
characteristics.characteristic: treatments